Diabetic kidney disease
Conditions
Brief summary
Urinary albumin-to-creatinine ratio (UACR) (Change from randomization to end of treatment at 3 months)
Detailed description
Measured GFR with plasma clearance of 99Tc-DTPA or eGFR measured with the CKD-EPI equation based on creatinine and/or cystatin C, 24 hours ambulatory blood pressure, Plasma PK parameters of R3R01
Interventions
DRUGTechnescan DTPA Radiofarmaceutisk præparationssæt
DRUGPlacebo
Sponsors
River 3 Renal Corp.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary albumin-to-creatinine ratio (UACR) (Change from randomization to end of treatment at 3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured GFR with plasma clearance of 99Tc-DTPA or eGFR measured with the CKD-EPI equation based on creatinine and/or cystatin C, 24 hours ambulatory blood pressure, Plasma PK parameters of R3R01 | — |
Countries
Denmark
Outcome results
None listed